← Eichor
Condition: Human Papillomavirus Related Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Human Papillomavirus Related Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
Phase 2 · 1 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06640283The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
Phase 2 · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT05419089De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Phase 2 · 3 location(s) · Mayo Clinic · NCT05541016Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples
NA · 1 location(s) · Universiteit Antwerpen · NCT06598176A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Wome
Phase 3 · 8 location(s) · National Vaccine and Serum Institute, China · NCT05262010Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma
NA · 1 location(s) · Case Comprehensive Cancer Center · NCT07060261A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papil
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05307939The Minimalist Trial-2
Phase 2 · 3 location(s) · Washington University School of Medicine · NCT06702033Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
Phase N/A · 2 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06305676Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Can
Phase 2 · 2 location(s) · Northwestern University · NCT07178301The Women's Screening and Self-Testing Program (PROMETA) Study
NA · 1 location(s) · Tulane University · NCT06810739Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck
NA · 1 location(s) · Yvonne Mowery · NCT07227792PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Phase 2 · 3 location(s) · Precigen, Inc · NCT06157151Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neopla
NA · 1 location(s) · PCK Marine Hospital in Gdynia · NCT06574087E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Phase 2 · 3 location(s) · Christian Hinrichs · NCT05686226LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT04665388ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
Phase 2 · 2 location(s) · Jennifer Dorth · NCT07425054Detecting HPV DNA in Anal and Cervical Cancers
Phase N/A · 2 location(s) · University of Chicago · NCT04857528E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Phase 1/Phase 2 · 2 location(s) · Christian Hinrichs · NCT05639972To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
Phase 2 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT06756269SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Phase 1 · 1 location(s) · The Affiliated Hospital of Qingdao University · NCT06544720A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
NA · 1 location(s) · Emory University · NCT07104240Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Phase 1 · 5 location(s) · National Cancer Institute (NCI) · NCT05985681Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Phase 2 · 2 location(s) · Emory University · NCT06636734A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Phase 1/Phase 2 · 4 location(s) · Theravectys S.A. · NCT06319963Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas
Phase N/A · 1 location(s) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Banglade · NCT06642324
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.